The Science of Sticky: Making Bandages Stay On Longer with Ultrasound Waves

A lone bandage floating in a kiddie pool. Medical tape peeling up at the edges. Adhesives gone rogue in the gastrointestinal space. Could these issues be a thing of the past? For a team of researchers from McGill University, ETH Zurich and UBC, that’s the dream. A study published in the journal Science found the stickiness of adhesive bandages can be manipulated with technology you’re likely already familiar with: ultrasound waves...READ MORE

GlycoNet Integrated Services Awarded $10.68 Million Investment from the Canadian Foundation for Innovation’s Major Science Initiative Fund

The Canada Foundation for Innovation recently announced its continued support of Canadian glycomics research with an investment of $10.68 million to GlycoNet Integrated Services (GIS) through its Major Science Initiatives Fund. GIS is the world’s largest and most advanced comprehensive suite of specialized glycomics tools and services. This glycomics “toolbox” uniquely equips academic and industrial researchers with the synthetic and analytical screening technologies needed to undertake world-class glycomics research and technology development...READ MORE

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine

Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization of a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older. The application follows guidance from the FDA to include clinical data from the companies’ bivalent Omicron BA.1-adapted vaccine and pre-clinical and manufacturing data from the companies’ bivalent Omicron BA.4/BA.5-adapted vaccine to address the continued evolution of SARS-CoV-2. Pending authorization, the Omicron BA.4/BA.5-adapted bivalent vaccine will be available to ship immediately...READ MORE

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure Takeda announced the company’s dengue vaccine, QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]), was approved by the Indonesia National Agency for Drug and Food Control, Badan Pengawas Obat dan Makanan, for the prevention of dengue disease caused by any serotype in individuals six years to 45 years of age. The use of QDENGA should be in accordance with official recommendations. QDENGA is the only dengue vaccine approved in Indonesia for use in individuals regardless of previous dengue exposure...READ MORE

Combining Genetics and Brain MRI Can Aid in Predicting Chances of Alzheimer’s Disease

In a newly published study, researchers from SFU’s Functional and Anatomical Imaging & Shape Analysis Lab identified distinct properties of brain MRIs and genetics that impact the prediction of Dementia of Alzheimer’s Type, or DAT, for patients at various stages of the disease, then developed a biomarker that can help predict future conversion to DAT...READ MORE

New Medtech Canada Board Chair

Message from John Simmons, Chair of the Board of Medtech Canada: Greetings Medtech Canada members, I am writing to inform you that I have stepped down in the role of Board Chair for our association. While I was very much looking forward to continuing in the role, AceAge – the company I have been leading – has been acquired. As a result of the acquisition, I have transitioned out of the business as it’s been folded into the operations of the company’s new partner...READ MORE

$11.8M Investment to Support Can-SOLVE CKD Network through 2027

The Can-SOLVE CKD Network is Canada’s largest-ever kidney research initiative. Since 2016, this national partnership of patients, scientists, and health care professionals has advanced innovative kidney care solutions to help the millions of Canadians affected by chronic kidney disease. A new investment announced by the Canadian Institutes of Health Research supports the continuation of this transformative work through 2027. Can-SOLVE CKD will receive $3.75 million in new funding from CIHR matched by more than $8 million raised through the generous support of more than 60 partners...READ MORE

Dr. Nadine Caron Recognized with B.C.’s Highest Honour

UNBC faculty member and UBC Northern Medical Program professor Dr. Nadine Caron is being recognized with an appointment to the Order of British Columbia. The award is British Columbia’s highest form of recognition. Dr. Caron is one of only 14 individuals from across B.C., and the only person from the north, to become a member of the Order in 2022. More than 190 British Columbians were nominated for the award this year. The Order was created in 1989 to recognize B.C. citizens who have served with distinction and excelled in their field of expertise to benefit all British Columbians...READ MORE

Program Team Lead

At Abdera Therapeutics, we are looking for curious and committed individuals who are ready for the opportunity to transform the way people living with cancer can be treated. We are relentless in our focus to offer new hope to families facing devastating diagnoses. We are in search of team members who work collaboratively with a diverse group of colleagues, respectfully engaging one another while collectively and inclusively tackling any challenges we may face. We are building an exciting and fast paced company passionate about discovering and developing tomorrow’s most innovative cancer therapies.

LEARN MORE

Research & Development Chemist

Alpha-9 is seeking a Research & Development Chemist to join our growing organization. The ideal candidate will have experience with solid-phase peptide synthesis, and preferably with radiopharmaceutical development. This person will be responsible for designing, planning and synthesizing peptides/peptidomimetic building blocks and precursors for radiopharmaceutical product candidates. 

We are an early-stage company, so you will have the opportunity to participate cross-functionally and contribute to the build-out and set-up of new laboratory facilities. The ideal candidate will have multi-tasking ability and a desire to strive in a fast-paced environment. 

LEARN MORE

Tenure-Track Assistant Professor Position, Pharmacology

We now invite applications for a full-time tenure-track Assistant Professor position in Pharmacology. Applicants for this position must possess a PhD or equivalent doctoral qualification, with research expertise that broadens our current strengths in cancer pharmacology, cardiovascular pharmacology, diabetes, drug metabolism/pharmacokinetics, neuropharmacology, and pharmacogenomics or complements these strengths with a research focus in pharmacology.

LEARN MORE

Integrated Nanotherapeutics Inc. (INT) is a biotech company that is developing novel lipid nanoparticle (LNP) platforms to improve delivery of small molecules and macromolecules, and to enable combination therapies for complex diseases.





Visit Website

ARTMS (Alternative Radioisotope Technologies for Medical Science) was created to enhance human health through innovation and leadership in medical isotope production. ARTMS is changing the Nuclear Medicine supply chain status quo.

Their Vision is to lead the enhancement of human health through medical isotope innovation by creating the tools, technologies and products that solidify medical isotope supply and empower the Nuclear Medicine community.

Visit Website